Bring us a problem
worth solving together.
MACRO HRD applies the GEDM-3DQ engine, our four platform technologies, and a global scientific network to therapeutic and diagnostic challenges that conventional approaches cannot resolve.
Research institutions, hospital networks, biotech founders, government health authorities, and pharmaceutical partners — particularly those facing a translation gap between strong science and clinical reality.
Whether your project benefits from integration with our cellular therapy platforms, antibody systems, peptide library, decision intelligence, or our infrastructure assets — biobanking, ambient logistics, ICU deployment, and special medical practice zones.
Every submission is reviewed by our scientific leadership. Where there is a fit, we respond within ten working days with a structured proposal for how MACRO HRD could participate — as collaborator, technology licensor, or co-development partner.
Tell us about your project.
The fields below are designed to give us a complete picture in a single submission. Please be specific — vague submissions take longer to evaluate.
Your project, treated with the care it deserves.
Submissions are reviewed only by named MACRO HRD scientific leadership. They are not stored on shared platforms and are not disclosed to third parties without explicit written consent.
MACRO HRD does not develop competing programs based on submissions received through this channel. If we believe there is a fit, we propose a path forward together — with you as the rightful originator.
Before any technical exchange begins beyond this initial brief, we sign a mutual non-disclosure agreement. We can use yours, or provide ours — whichever you prefer.
You may withdraw your submission at any time, for any reason, by writing to info@macrohrd.com. Upon request, we will confirm deletion in writing.